Unexpected effects of FERM domain mutations on catalytic activity of Jak3: Structural implication for Janus kinases

被引:109
作者
Zhou, YJ
Chen, M
Cusack, NA
Kimmel, LH
Magnuson, KS
Boyd, JG
Lin, W
Roberts, JL
Lengi, A
Buckley, RH
Geahlen, RL
Candotti, F
Gadina, M
Changelian, PS
O'Shea, JJ [1 ]
机构
[1] NIAMSD, Lymphocyte Cell Biol Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA
[2] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA
[3] Pfizer Inc, Global Res & Dev, Dept Immunol, Groton, CT 06340 USA
[4] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA
[5] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/S1097-2765(01)00398-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Janus kinases comprise carboxyterminal kinase, pseudokinase, SH2-like, and N-terminal FERM domains. We identified three patient-derived mutations in the FERM domain of Jak3 and investigated the functional consequences of these mutations. These mutations inhibited receptor binding and also abrogated kinase activity, suggesting interactions between the FERM and kinase domains. In fact, the domains were found to physically associate, and coexpression of the FERM domain enhanced activity of the isolated kinase domain. Conversely, staurosporine, which alters kinase domain structure, disrupted receptor binding, even though the catalytic activity of Jak3 is dispensable for receptor binding. Thus, the Jak FERM domain appears to have two critical functions: receptor interaction and maintenance of kinase integrity.
引用
收藏
页码:959 / 969
页数:11
相关论文
共 35 条
  • [1] Development of inhibitors for protein tyrosine kinases
    Al-Obeidi, FA
    Lam, KS
    [J]. ONCOGENE, 2000, 19 (49) : 5690 - 5701
  • [2] Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
    Biondi, RM
    Cheung, PCF
    Casamayor, A
    Deak, M
    Currie, RA
    Alessi, DR
    [J]. EMBO JOURNAL, 2000, 19 (05) : 979 - 988
  • [3] Selected glimpses into the activation and function of Src kinase
    Bjorge, JD
    Jakymiw, A
    Fujita, DJ
    [J]. ONCOGENE, 2000, 19 (49) : 5620 - 5635
  • [4] Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain
    Cacalano, NA
    Migone, TS
    Bazan, F
    Hanson, EP
    Chen, M
    Candotti, F
    O'Shea, JJ
    Johnston, JA
    [J]. EMBO JOURNAL, 1999, 18 (06) : 1549 - 1558
  • [5] Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains
    Chen, M
    Cheng, A
    Candotti, F
    Zhou, YJ
    Hymel, A
    Fasth, A
    Notarangelo, LD
    O'Shea, JJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) : 947 - 956
  • [6] The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals
    Chen, M
    Cheng, A
    Chen, YQ
    Hymel, A
    Hanson, EP
    Kimmel, L
    Minami, Y
    Taniguchi, T
    Changelian, PS
    OShea, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6910 - 6915
  • [7] COLBURN JC, 1987, METHOD ENZYMOL, V139, P188
  • [8] MULTIPLE SEQUENCE ALIGNMENT WITH HIERARCHICAL-CLUSTERING
    CORPET, F
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (22) : 10881 - 10890
  • [9] Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
    Druker, BJ
    Lydon, NB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) : 3 - 7
  • [10] Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2
    Eblen, ST
    Catling, AD
    Assanah, MC
    Weber, MJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (01) : 249 - 259